Convalescent Covid-19 plasma: Back-to-basics and ethics, and next steps.

Garraud, O; Burnouf, T

Garraud, O; Burnouf, T.

Garraud O; Transfusion Clinique et Biologique, inserm_1059, university of Lyon, Faculty of medicine of Saint-Etienne, 42000 Saint-Etienne, France. Electronic address: olivier.garraud@univ-st-etienne.fr.
Burnouf T; Transfusion Clinique et Biologique, Graduate Institute of Biomedical Materials and Tissue Engineering & International PhD Program in Biomedical Engineering, College of Biomedical Engineering, Taipei Medical University, Taipei, Taiwan.

Transfus Clin Biol ; 28(3): 225-227, 2021 08.

Article in English | MEDLINE | ID: covidwho-1336978

Subject(s)

COVID-19/therapy; Pandemics; SARS-CoV-2; Antibodies, Viral/immunology; Antibodies, Viral/therapeutic use; Blood Safety; Blood-Borne Infections/prevention & control; COVID-19/epidemiology; COVID-19/prevention & control; COVID-19 Vaccines/supply & distribution; Developing Countries; Forecasting; Humans; Immunization, Passive/ethics; Immunization, Passive/standards; International Cooperation; Quality Control; SARS-CoV-2/genetics; SARS-CoV-2/immunology; Treatment Outcome; COVID-19 Serotherapy

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pandemics / SARS-CoV-2 / COVID-19 Type of study: Observational study / Prognostic study Topics: Vaccines Limits: Humans Language: English Journal: Transfus Clin Biol Journal subject: Hematology Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google